The QuadVantage team is highly experienced and invested in the Company. In addition, advisors with significant experience in the field have been added that augment the team’s ability to develop products that truly meet the needs of orthopedic doctors that are engaged in the quest for a better solution day in and day out.
The team has built a strong intellectual property portfolio and completed human clinical trials (over 100 cases) successfully.
40 years of CEO, President, COO and General Management level responsibility leading the development and operation of highly technical public, private and private equity-controlled companies serving the capital equipment, advanced materials, consumables, electronic component, medical and service industries. Entities ranged in size from pre-revenue to $3 Billion in annual revenue. Extensive M&A, IPO and world-wide R&D, Manufacturing, Marketing, Financial and Operations experience. Former CEO of Invensys plc Power Systems, BTR plc Sensors, Xerium Technologies (NYSE), GT Advanced Technologies (NASDAQ), Oliventures Inc., and President of various Pitney Bowes businesses. Early career as an R&D and manufacturing engineer and manufacturing manager at Harris Semiconductor, Magnavox, Digital Equipment Corporation, Motorola and NCR. In addition to current responsibilities as CEO/CFO of QuadVantage, Mr. Gutierrez runs a consulting business, Obsidian Technology LLC, of which he is the sole owner.
Dr. Paul L. Burroughs, III, a graduate of the University of North Carolina Medical School, has over 20 years of experience as a physician in Orthopedic Surgery and Sports Medicine. He specializes in arthroscopy of the knee and shoulder, advanced joint replacement techniques, knee replacements utilizing Exparel pain management and sports medicine. He also performs partial knee replacements, ACL ligament reconstruction, rotator cuff repairs, reconstruction of shoulder dislocations, and ultrasound guided injections. Dr. Burroughs is certified by the American Board of Orthopedic Surgeons and is published in the American Journal of Sports Medicine and the Journal of Arthroplasty. Dr. Burroughs serves as the Company’s Chairman and non-executive CMO (Chief Medical Officer).
Ms. Gutierrez has a BSBA (Business and Accounting) and MBA from The Ohio State University and has over 20 years of senior level experience in finance. She served as an Auditor/CPA at Ernst and Whinney (predecessor to E&Y), as Controller at Berwick Steel, Scientific Columbus and Daytronic Corporation and as group Controller at various Invensys plc businesses. Ms. Gutierrez is retired and has served as CFO of various Gutierrez family businesses and as QuadVantage’s Chief Accounting Officer since its inception.
Clinical Research Scientist with extensive experience in ACL surgery methods at the Steadman Clinic in Colorado as a surgical assistant to leading surgeons in the space. Focused on establishing research partnerships with thought leaders in the ACL reconstruction market on behalf of QuadVantage. DePhillipo has extensive contacts in the industry and is highly regarded as a subject matter expert.
Dr. McMillan is a board-certified orthopedic sports medicine surgeon. He has published in many textbooks and peer reviewed journals and specializes in minimally invasive surgery of the shoulder, hip and knee. Vice Chair of Surgery: Virtua Willingboro Hospital, Chief of Orthopedics: Virtua Our Lady of Lourdes Hospital & Virtua Willingboro Hospital and Director of Orthopedic Sports Medicine and Arthroscopy at Virtua Medical Group.
As of 2-21-2023, QuadVantage terminated its Reg CF offering. However, the company continues to look for qualified investors interested in investing in the company as it prepares to commercialize its products during Q1 of 2023.
If interested in investing please contact firstname.lastname@example.org via email.